Printer Friendly
The Free Library
14,505,807 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Ono Licenses Cancer Anorexia/Cachexia Drug from Sapphire Therapeutics for Japan, Korea and Taiwan.


Tokyo, Japan, Oct 26, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Ono Pharmaceutical announced October 26 that it signed a licensing agreement with US-based Sapphire Therapeutics for a novel drug candidate, RC-1291, for the treatment of cancer anorexia/cachexia.

Ono has obtained the exclusive rights to develop and commercialize RC-1291 in Japan, Korea and Taiwan under this agreement, and in consideration of such rights Ono will pay to Sapphire upfront and milestone payments as well as royalties on sales of RC-1291.

RC-1291, designated as a fast-track drug candidate by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 for cancer anorexia/cachexia, is an orally active synthetic small molecule ghrelin mimetic mimetic /mi·met·ic/ (mi-met´ik) pertaining to or exhibiting imitation or simulation, as of one disease for another.

mi·met·ic
adj.
1. Of or exhibiting mimicry.

2.
.

A Phase II study is currently being conducted by Sapphire with cancer anorexia/cachexia patients in the USA. In addition, Ono plans to start Phase I study in Japan in the second quarter of 2007.

Ghrelin is a circulating peptide hormone Peptide hormones are a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.

Like other proteins, peptide hormones are synthesized from amino acids according to an mRNA template, which is itself synthesized from a DNA
 principally produced in stomach cells that has multiple physiological actions, including appetite stimulation and muscle-building (anabolic anabolic

pertaining to or arising from anabolism.


anabolic steroid
steroids with a tissue-building effect. Testosterone is an example of a natural anabolic steroid with the, sometimes undesirable, effect of causing masculinization.
) effects.

RC-1291 is a synthetic small molecule with similar physiological actions, like appetite stimulation and muscle-building effects, to those of ghrelin. Unlike ghrelin though, RC-1291 can be administered as an oral treatment.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 26, 2006
Words:198
Previous Article:Morinaga Milk Announces Research Results of Lactoferrin on Peridontal Disease.
Next Article:Daiichi Pharmaceutical Receives Import Approval for Ultrasound Contrast Medium Sonazoid.



Related Articles
Compound may cause wasting seen in cancer. (compound found in cancer patients' urine that promotes wasting, also known as cachexia)(Brief Article)
PHARMASSET TO DEVELOP CLEVUDINE FOR HEPATITIS B.
Ono Pharmaceutical Announces Changes in Investigational AIDS Drug Development Program.
Ono Pharmaceutical, Array BioPharma to Collaborate in Kinase-targeted Drug Discovery.
BIOCRYST/GREEN CROSS TO DEVELOP PERAMIVIR IN SOUTH KOREA.
Banyu and Ono Begins Phase III Clinical Trials of a DPP-4 Inhibitor for Type 2 Diabetes Patients.
Evidence based statements.
Drug approval.(News of the Week)(Abraxis BioScience Inc)(Brief article)
Ono Pharmaceutical Announces Establishment of Strategic Alliance Headquarters.
ARQULE/KYOWA HAKKO KOGYO SIGN ARQ 197 ASIA LICENSE.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles